Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ATSDR), Lead Poisoning Prevention (LPP) Subcommittee, 55458-55459 [2016-19788]
Download as PDF
55458
Federal Register / Vol. 81, No. 161 / Friday, August 19, 2016 / Notices
need to present valid government-issued
picture identification, and sign-in at the
security desk upon entering the
building.
Attendees who wish to attend the
September 13–14, 2016 ICD–10–CM
C&M meeting must submit their name
and organization by September 2, 2016
for inclusion on the visitor list. This
visitor list will be maintained at the
front desk of the CMS building and used
by the guards to admit visitors to the
meeting.
Participants who attended previous
Coordination and Maintenance meetings
will no longer be automatically added to
the visitor list. You must request
inclusion of your name prior to each
meeting you wish to attend.
Please register to attend the meeting
on-line at: https://www.cms.hhs.gov/
apps/events/. Please contact Mady Hue
(410–786–4510 or Marilu.hue@
cms.hhs.gov), for questions about the
registration process.
Purpose: The ICD–10 Coordination
and Maintenance (C&M) Committee is a
public forum for the presentation of
proposed modifications to the
International Classification of Diseases,
Tenth Revision, Clinical Modification
and ICD–10 Procedure Coding System.
Matters To Be Discussed: Agenda
items include:
September 13–14, 2016.
ICD–10–PCS Topics
Administration of Influenza Vaccine
Administration of Peptide Enhanced
Bone Graft
Balloon Atrial Septostomy
Extracorporeal Carbon Dioxide Removal
Extracorporeal Treatment of Vascular
Grafts
Intramuscular Autologous Bone Marrow
Cell Therapy
Resuscitative Endovascular Balloon
Occlusion of the Aorta
Addenda and Key Updates
mstockstill on DSK3G9T082PROD with NOTICES
ICD–10–CM Diagnosis Topics
Abnormality in Fetal Heart Rate or
Rhythm
Acute Appendicitis
Acute Cholecystitis
Acute Respiratory Distress
Amyloidosis
Antenatal Screening
Atrial Fibrillation (AF)
ATV and Motor-cross Vehicle Injuries
Body Integrity Dysphoria
Disease of Intestine
E-cigarette Use
Hepatic Diverticular Encephalopathy
Injury to Optic Tract and Visual Cortex
Intestinal Obstruction
Neonatal Encephalopathy
Obstetrical Issues
Parrots/Macaws Modifications
VerDate Sep<11>2014
18:08 Aug 18, 2016
Jkt 238001
Personal History of Mesothelioma and
Secondary Mesothelioma
Primary and Central Hypothyroidism
Post Endometrial Ablation Syndrome
Pulmonary Arterial Hypertension (representation)
Sickle Cell w/o Acute Chest Syndrome
or Splenic Sequestration
Spinal Stenosis With Neurogenic
Claudication
Surgical Site Infection
Types of MI
Umbilical Granuloma in the Perinatal
Period
Zika Related Newborn Conditions
Agenda items are subject to change as
priorities dictate.
Note: CMS and National Center for Health
Statistics (NCHS) no longer provide paper
copies of handouts for the meeting.
Electronic copies of all meeting materials
will be posted on the CMS and NCHS Web
sites prior to the meeting at https://
www.cms.hhs.gov/
ICD9ProviderDiagnosticCodes/03_
meetings.asp#TopOfPage and https://
www.cdc.gov/nchs/icd/icd9cm_
maintenance.htm.
Contact Persons for Additional
Information: Donna Pickett, Medical
Systems Administrator, Classifications
and Public Health Data Standards Staff,
NCHS, 3311 Toledo Road, Hyattsville,
Maryland 20782, email dfp4@cdc.gov,
telephone 301–458–4434 (diagnosis);
Mady Hue, Health Insurance Specialist,
Division of Acute Care, CMS, 7500
Security Boulevard, Baltimore,
Maryland 21244, email marilu.hue@
cms.hhs.gov, telephone 410–786–4510
(procedures).
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–19790 Filed 8–18–16; 8:45 am]
BILLING CODE 4160–18–P
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/
ATSDR), Lead Poisoning Prevention
(LPP) Subcommittee
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the CDC, National
Center for Environmental Health/
Agency for Toxic Substances and
Disease Registry (NCEH/ATSDR)
announces the following meeting of the
aforementioned committee:
Time and Date: 8:30 a.m.—3:15 p.m.
EDT, September 19, 2016.
Place: CDC, 4770 Buford Highway,
Building 106, Conference Room 1/A,
Atlanta, Georgia 30341. The meeting
will also be held by teleconference. To
participate in the teleconference, please
dial 1–866–687–6445, passcode
5598486.
Status: The meeting is open to the
public, the conference room
accommodates approximately 60 people
and will be limited only by the space
available. The public is welcome to
participate during the public comment
period which is scheduled from 10:15
a.m. until 10:30 a.m. EST (15 minutes).
Individuals wishing to make a
comment during the public comment
period or to attend the meeting in
person, please email your name,
organization, and phone number by
Thursday, September 15, 2016 to
Amanda Malasky at AMalasky@cdc.gov.
Purpose: The subcommittee will
discuss strategies and options on ways
to prioritize NCEH/ATSDR’s activities,
improve health outcomes, and address
health disparities as it relates to lead
exposures. The subcommittee will
deliberate on ways to evaluate lead
exposure and how to best conduct
health evaluations through exposure
and epidemiologic studies.
Subcommittee proposals on lead
prevention practices and national lead
poisoning prevention efforts will be
provided to the Board of Scientific
Counselors for deliberation and possible
adoption as formal recommendations to
NCEH/ATSDR.
Matters for Discussion: Agenda items
will include the following: NCEH/
ATSDR support for the public health
emergency in Flint; rethinking the
strategy for the NCEH Lead Surveillance
Program; CDC’s Blood Reference Value
for Lead; other emerging lead topics;
E:\FR\FM\19AUN1.SGM
19AUN1
Federal Register / Vol. 81, No. 161 / Friday, August 19, 2016 / Notices
advice, guidance, recommendations,
and summary and next steps.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Amanda Malasky, Coordinator, Lead
Poisoning Prevention Subcommittee,
BSC, NCEH/ATSDR, 4770 Buford
Highway, Mail Stop F–45, Chamblee,
Georgia 30345; telephone 770/488–
7699, Fax: 770/488–3377; Email:
AMalasky@cdc.gov.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director,
Management Analysis and Services Office,
Centers for Disease Control and Prevention.
[FR Doc. 2016–19788 Filed 8–18–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK3G9T082PROD with NOTICES
Board of Scientific Counselors,
National Center for Health Statistics:
Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center for Health Statistics (NCHS)
announces the following meeting of the
aforementioned committee.
Times and Dates: 11 a.m.–5:30 p.m.,
EDT, September 15, 2016. 8:30 a.m.–1
p.m., EDT, September 16, 2016.
Place: NCHS Headquarters, 3311
Toledo Road, Hyattsville, Maryland
20782.
Status: This meeting is open to the
public; however, visitors must be
processed in accordance with
established federal policies and
procedures. For foreign nationals or
non-U.S. citizens, pre-approval is
required (please contact Gwen Mustaf,
301–458–4500, glm4@cdc.gov, or
Virginia Cain, vcain@cdc.gov at least 10
days in advance for requirements). All
visitors are required to present a valid
form of picture identification issued by
a state, federal or international
government. As required by the Federal
Property Management Regulations, title
41, Code of Federal Regulation, subpart
101–20.301, all persons entering in or
VerDate Sep<11>2014
18:08 Aug 18, 2016
Jkt 238001
on Federal controlled property and their
packages, briefcases, and other
containers in their immediate
possession are subject to being x-rayed
and inspected. Federal law prohibits the
knowing possession or the causing to be
present of firearms, explosives and other
dangerous weapons and illegal
substances. The meeting room
accommodates approximately 100
people.
Purpose: This committee is charged
with providing advice and making
recommendations to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NCHS, regarding the scientific
and technical program goals and
objectives, strategies, and priorities of
NCHS.
Matters for Discussion: The agenda
will include:
1. Welcome remarks by the Director,
NCHS
2. Presentation on Race and Ethnicity in
Vital Statistics
3. Presentation on Improving the
Quality of Cause of Death Reporting
4. Presentation on New Data on Births
5. Presentation on Research Data
Centers Expansion
Requests to make oral presentations
should be submitted in writing to the
contact person listed below. All requests
must contain the name, address,
telephone number, and organizational
affiliation of the presenter.
Written comments should not exceed
five single-spaced typed pages in length
and must be received by September 6,
2016.
The agenda items are subject to
change as priorities dictate.
Contact Person for More Information:
Virginia S. Cain, Ph.D., Director of
Extramural Research, NCHS/CDC, 3311
Toledo Road, Room 7208, Hyattsville,
Maryland 20782, telephone (301) 458–
4500, fax (301) 458–4024.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Elaine L. Baker,
Management Analysis and Services Office,
Centers for Disease Control and Prevention.
[FR Doc. 2016–19789 Filed 8–18–16; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
55459
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health Subcommittee for Dose
Reconstruction Reviews, National
Institute for Occupational Safety and
Health Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10:30 a.m.–5 p.m.,
EDT, September 13, 2016.
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public, but
without a public comment period. The
public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcome to listen to the meeting by
joining the teleconference at the USA
toll-free, dial-in number at 1–866–659–
0537 and the pass code is 9933701.
Background: The Advisory Board on
Radiation and Worker Health (ABRWH
or the Advisory Board) was established
under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort.
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC.
National Institute for Occupational
Safety and Health (NIOSH) implements
this responsibility for CDC. The charter
was issued on August 3, 2001, renewed
at appropriate intervals, rechartered on
E:\FR\FM\19AUN1.SGM
19AUN1
Agencies
[Federal Register Volume 81, Number 161 (Friday, August 19, 2016)]
[Notices]
[Pages 55458-55459]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-19788]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Board of Scientific Counselors, National Center for Environmental
Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/
ATSDR), Lead Poisoning Prevention (LPP) Subcommittee
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the CDC, National Center for
Environmental Health/Agency for Toxic Substances and Disease Registry
(NCEH/ATSDR) announces the following meeting of the aforementioned
committee:
Time and Date: 8:30 a.m.--3:15 p.m. EDT, September 19, 2016.
Place: CDC, 4770 Buford Highway, Building 106, Conference Room 1/A,
Atlanta, Georgia 30341. The meeting will also be held by
teleconference. To participate in the teleconference, please dial 1-
866-687-6445, passcode 5598486.
Status: The meeting is open to the public, the conference room
accommodates approximately 60 people and will be limited only by the
space available. The public is welcome to participate during the public
comment period which is scheduled from 10:15 a.m. until 10:30 a.m. EST
(15 minutes).
Individuals wishing to make a comment during the public comment
period or to attend the meeting in person, please email your name,
organization, and phone number by Thursday, September 15, 2016 to
Amanda Malasky at AMalasky@cdc.gov.
Purpose: The subcommittee will discuss strategies and options on
ways to prioritize NCEH/ATSDR's activities, improve health outcomes,
and address health disparities as it relates to lead exposures. The
subcommittee will deliberate on ways to evaluate lead exposure and how
to best conduct health evaluations through exposure and epidemiologic
studies. Subcommittee proposals on lead prevention practices and
national lead poisoning prevention efforts will be provided to the
Board of Scientific Counselors for deliberation and possible adoption
as formal recommendations to NCEH/ATSDR.
Matters for Discussion: Agenda items will include the following:
NCEH/ATSDR support for the public health emergency in Flint; rethinking
the strategy for the NCEH Lead Surveillance Program; CDC's Blood
Reference Value for Lead; other emerging lead topics;
[[Page 55459]]
advice, guidance, recommendations, and summary and next steps.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Amanda Malasky, Coordinator,
Lead Poisoning Prevention Subcommittee, BSC, NCEH/ATSDR, 4770 Buford
Highway, Mail Stop F-45, Chamblee, Georgia 30345; telephone 770/488-
7699, Fax: 770/488-3377; Email: AMalasky@cdc.gov.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director,
Management Analysis and Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016-19788 Filed 8-18-16; 8:45 am]
BILLING CODE 4163-18-P